Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2021-03-04 2021-03-04
Drug Identification Number 02481499 02481499
Brand name APO-DASATINIB APO-DASATINIB
Common or Proper name DASATINIB DASATINIB
Company Name APOTEX INC APOTEX INC
Ingredients DASATINIB DASATINIB
Strength(s) 70MG 70MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 BLS 30 BLS
ATC code L01XE L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-16 2021-02-16
Estimated end date 2021-03-02 2021-03-02
Actual end date 2021-03-01 2021-03-01
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments